The development of TDP43 mice, which might better reflect most human ALS, might afford a truer disease model than the SOD1 mouse, and it may be useful to revisit promising agents minimally successful in SOD1 studies (such as MB), in TDP43 mice. This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.